Testing SIM0689 for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new drug called SIM0689 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug is safe and effective, and researchers will look at tumor samples to understand which patients might benefit most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your cancer must be advanced (has spread to other parts of the body) and standard treatments have not worked, are not available, or you have chosen not to have them.
- You must have at least one tumor that can be measured on scans (like a CT scan).
- You must be well enough to be up and about (ECOG score 0 or 1).
- You must have a tumor sample available for testing, or be willing to have a new biopsy.
- You must not have untreated or symptomatic brain metastases.
- You must not have a history of serious bleeding, stomach/intestinal problems, or blood clotting disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug (SIM0686) in people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and how it affects tumors that have a specific protein called FGFR2b on their surface.
This trial tests an investigational new drug, SIM0609, for people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see early signs that it might help slow or shrink tumors.
This is an early-stage trial testing a new drug called SIM0613 for advanced cancers that have spread or grown despite other treatments. The drug is designed to target cancer cells using a special delivery system.
This trial tests a new drug called SIM0610 for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to see if the drug is safe and effective.
This trial tests a combination of two experimental drugs, Simmitinib and SG001, in people with advanced solid tumors that have stopped responding to standard treatments. It aims to find out if this combination is safe and effective.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
Hear when a new Neoplasms, Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.